Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ohman

Showing results (151-160 of 186) with videos related to

Pageof 19
Sort By:
European Heart Journal|November 10, 2000
Lack of progress in cardiogenic shock: lessons from the GUSTO trialsV Menon, J S Hochman, A Stebbins, et al.
American Heart Journal|May 29, 1999
Hemodynamic effects of new intra-aortic balloon counterpulsation timing methods in patients: a multicenter evaluationM J Kern, F V Aguirre, E A Caracciolo, et al.
Circulation|October 10, 1997
Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7R H Christenson, E M Ohman, E J Topol, et al.
Journal of the American College of Cardiology|November 30, 1999
Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesM G Cohen, C B Granger, E M Ohman, et al.
Heart (British Cardiac Society)|June 17, 2005
Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patternsP Kaul, L K Newby, Y Fu, et al.
The American Journal of Cardiology|December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary ArteriesE M Ohman, P W Armstrong, H D White, et al.
Clinical Chemistry|March 25, 1998
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa InvestigatorsR H Christenson, S H Duh, L K Newby, et al.
JAMA|March 13, 1996
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigatorsW D Weaver, H D White, R G Wilcox, et al.
The American Journal of Cardiology|March 1, 1997
Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intraaortic Balloon PumpJ D Talley, E M Ohman, D B Mark, et al.
Circulation|December 19, 2007
Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapyJeffrey S Berger, Amanda Stebbins, Christopher B Granger, et al.
Pageof 19

Showing results (151-160 of 186) with videos related to

Sort By:
Pageof 19
European Heart Journal|November 10, 2000
Lack of progress in cardiogenic shock: lessons from the GUSTO trialsV Menon, J S Hochman, A Stebbins, et al.
American Heart Journal|May 29, 1999
Hemodynamic effects of new intra-aortic balloon counterpulsation timing methods in patients: a multicenter evaluationM J Kern, F V Aguirre, E A Caracciolo, et al.
Circulation|October 10, 1997
Assessment of coronary reperfusion after thrombolysis with a model combining myoglobin, creatine kinase-MB, and clinical variables. TAMI-7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction-7R H Christenson, E M Ohman, E J Topol, et al.
Journal of the American College of Cardiology|November 30, 1999
Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary ArteriesM G Cohen, C B Granger, E M Ohman, et al.
Heart (British Cardiac Society)|June 17, 2005
Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patternsP Kaul, L K Newby, Y Fu, et al.
The American Journal of Cardiology|December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary ArteriesE M Ohman, P W Armstrong, H D White, et al.
Clinical Chemistry|March 25, 1998
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa InvestigatorsR H Christenson, S H Duh, L K Newby, et al.
JAMA|March 13, 1996
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigatorsW D Weaver, H D White, R G Wilcox, et al.
The American Journal of Cardiology|March 1, 1997
Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intraaortic Balloon PumpJ D Talley, E M Ohman, D B Mark, et al.
Circulation|December 19, 2007
Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapyJeffrey S Berger, Amanda Stebbins, Christopher B Granger, et al.
Pageof 19